Newswise — The final results from a national phase 2 study including researchers from Yale Cancer Center show the drug tipifarnib increased survival rates for patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). The findings are being..
Researchers have found a new way of accelerating wound healing using lactic acid bacteria as vectors to produce and deliver a human chemokine on site in the wounds…